Items tagged with Drug-resistant TB
Study finds increased survival and cure rates for patients with HIV and MDR-TB when infections treated concurrently (post)
Patients co-infected with HIV and multidrug-resistant tuberculosis (MDR-TB) can achieve similar survival and tuberculosis cure rates to those infected with MDR-TB but not HIV when treated concurrently for both infections, according to a new study published in the journal Clinical Infectious Diseases. The study was led by investigators at the Emory Rollins School of Public Health, in collaboration with Albert Einstein College of Medicine, the University of KwaZulu-Natal and the U.S. Centers for Disease Control and Prevention.
Bedaquiline and delamanid effective in multidrug-resistant TB (post)
Bedaquiline and delamanid were effective and safe for the treatment of multidrug-resistant tuberculosis (MDR-TB), according to the results of a study published in the European Respiratory Journal.
GDI Core Group: Call for applications (post)
The Global Drug−resistant TB Initiative (GDI) secretariat announced a "Call for applications" for new members of the GDI Core Group for the 2018-2020 term.
Scientists have a promising new approach for treating drug-resistant TB (post)
In research that promises a new approach to treating an age-old human scourge, scientists have found a way to weaken the bacterium that causes tuberculosis and boost its vulnerability to drugs that are rapidly losing their power to cure.
Unitaid seeks to fund innovative projects against TB and drug-resistance (post)
Unitaid launched a call for proposals for projects that will fight tuberculosis and its drug-resistant strains through innovative diagnostics, wider use of the best new drugs for adults and children, and new technologies that remind patients to take their medicines on schedule.
Managing MDR tuberculosis in Nepal (post)
The burden of multidrug and extensively drug resistant tuberculosis might be underevaluated among Nepalis, threatening bordering countries. Sophie Cousins reports from Kathmandu.
Parliamentary Assembly of the Council of Europe adopts Resolution on DR-TB in Europe (post)
On 10 May 2018, the Parliamentary Assembly of the Council of Europe adopted Resolution on Drug-resistant tuberculosis in Europe. The resolution will go to all 47 Ministers of Foreign Affairs of the Council of Europe countries this summer (before the UN High-Level Meeting on TB).
TB: pharmacists develop new substance to counteract antimicrobial resistance (post)
Antimicrobial resistance is on the rise worldwide. This is becoming a problem for infectious diseases like tuberculosis as there are only a few active substances available to combat such diseases. Pharmacists at Martin Luther University Halle-Wittenberg (MLU) have now found a way to increase the efficacy of a common tuberculosis agent while, at the same time, reducing resistance to it. The research group presents its latest developments in the international journal Molecules.
Global AMR R&D Hub launched (post)
Countries, organisations and foundations came together today (May 22) alongside the annual World Health Assembly to launch the Global Antimicrobial Resistance Research and Development Hub (Global AMR R&D Hub).
Could a new universal TB regimen help end the TB pandemic? (post)
As tuberculosis (TB) is the world's most lethal infectious disease, there is an urgent need to improve the treatment of this bacterial infection. One approach under consideration is the institution of a universal or “pan-TB” regimen comprising new agents capable of treating multidrug-resistant (MDR) and even extensively drug-resistant (XDR) TB.
Page 50 of 117 · Total posts: 0
←First 49 50 51 Last→